Investors’ outlook regarding the stock price performance over the year has been split, with some feeling optimistic and others feeling pessimistic, as it’s been a mixed bag. Until today this year the stock’s price performance recorded an increase of 58.46%. However, over the last six months, the performance has been stronger by -11.21%. The price of DMAC increased 41.10% over the last 30 days. And in the last five days, it has surged by 29.40%.
DiaMedica Therapeutics Inc (DMAC) current stock price is $5.15. During the last trading session, the stock soared, reaching $11.0 after opening at $5.15. The stock’s lowest point was $8.0 before it closed at $4.6.
DiaMedica Therapeutics Inc’s stock has seen a rocky market performance. The company’s stock achieved a 1-year high of $6.82 on 02/19/25, and the lowest price during that time was $3.19, recorded on 04/07/25.
52-week price history of DMAC Stock
The history of a stock’s 52-week high and low prices can provide important information about its current state and future potential. DiaMedica Therapeutics Inc’s current trading price is -24.47% away from its 52-week high, while its distance from the 52-week low is 61.44%. The stock’s price range for this period has been between $3.19 and $6.82. The Healthcare sector company’s shares saw a trading volume of about 0.63 million for the day, which was higher than the average daily volume of 0.22 million over the last three months.
The Connection Between Financial Performance and Market Capitalization
DiaMedica Therapeutics Inc (DMAC) has experienced a quarterly rise of 32.73% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 220.85M and boasts a workforce of 28 employees.
How Moving Averages and Trading Volume Data Work Together
Based on Barchart.com data, the company’s moving average over the 100-day period was 4.23, with a change in price of -1.23. Similarly, DiaMedica Therapeutics Inc recorded 176,774 in trading volume during the last 100 days, posting a change of -19.28%.
DMAC’s Debt-to-Equity Ratio: A Comprehensive Review
A key metric for assessing a company’s financial well-being and market status is the debt-to-equity (D/E) ratio. This ratio is derived by dividing a company’s total liabilities by its shareholders’ equity, and it demonstrates the level of debt a company uses to support its assets relative to shareholder equity. At the time of writing, the total D/E ratio for DMAC stands at 0.01. Similarly, the long-term debt-to-equity ratio is also 0.01.
DMAC Stock Stochastic Average
As of today, the raw stochastic average of DiaMedica Therapeutics Inc over the past 50 days is 94.37%. This is a increase compared to the raw stochastic average of the last 20 days, which was recorded at 94.37%. Additionally, the Stochastic %K and %D values for the company were 78.10% and 71.19%, respectively, over the past 20 days.
